Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is an experimental small molecule belonging to the class of 2-benzylamino-s-triazines and pyrazolo[1,5-a][1,3,5]triazines. It has not been approved for any indication and is not currently in clinical trials beyond preclinical or early research phases. The primary known mechanism of action is inhibition of cyclin-dependent kinase 2 (CDK2), a serine/threonine protein kinase involved in cell cycle regulation. CDK inhibitors are being explored as potential anticancer agents due to their ability to block cell proliferation by interfering with key checkpoints in the cell cycle.[1]
- Other names
- (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol
02
Targets
CDK2 (Cyclin-dependent kinase 2)
Beyond the preview
Go deeper on (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol.